A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/50 (2006.01) A61K 31/535 (2006.01) A61K 31/54 (2006.01) A61P 3/10 (2006.01) A61P 19/10 (2006.01) A61P 35/00 (2006.01) A61P 37/00 (2006.01)
Patent
CA 2460135
The invention relates to the use of Phosphodiesterase IV inhibitors and/or the physiologically acceptable salts thereof in the production of a medicament for the treatment of osteoporosis, tumors, tumor metastases, atherosclerosis, rheumatoid arthritis, multiple sclerosis, diabetes mellitus, ulzerative colitis and AIDS.
L'invention concerne l'utilisation d'inhibiteurs de la phosphodiestérase IV ou de leurs sels physiologiquement acceptables pour produire un médicament servant à traiter l'ostéoporose, des tumeurs, des métastases tumorales, l'athérosclérose, l'arthrite rhumatoïde, la sclérose en plaques, le diabète sucré, la rectocolite hémorragique et le SIDA.
Eggenweiler Hans-Michael
Wolf Michael
Fetherstonhaugh & Co.
Merck Patent Gesellschaft Mit Beschraenkter Haftung
LandOfFree
Use of pyridazinone compounds as phosphodiesterase iv... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of pyridazinone compounds as phosphodiesterase iv..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of pyridazinone compounds as phosphodiesterase iv... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1535304